- Conditions
- Premature Birth
- Interventions
- Cervical cerclage, Vaginal progesterone
- Procedure · Drug
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 93 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2024
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Preterm Delivery, Short Cervix, Short Uterine Cervical Length
- Interventions
- progesterone, placebo
- Drug
- Lead sponsor
- Juniper Pharmaceuticals, Inc.
- Industry
- Eligibility
- 15 Years to 45 Years · Female only
- Enrollment
- 465 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 27
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Orange, California + 21 more
- Conditions
- Preterm Delivery, Cervical Length
- Interventions
- 17 alpha-hydroxyprogesterone caproate, Placebo Oil
- Drug · Other
- Lead sponsor
- The George Washington University Biostatistics Center
- Other
- Eligibility
- Female only
- Enrollment
- 657 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2011
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Chicago, Illinois • Detroit, Michigan + 11 more
- Conditions
- Focus: Prevent Preterm Delivery, Incidental Short Cervix at Mid-trimester
- Interventions
- Arabin Pessary
- Drug
- Lead sponsor
- University of Illinois at Chicago
- Other
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Preterm Birth, Short Cervical Length
- Interventions
- Not listed
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 89 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 4
- States / cities
- Indianapolis, Indiana • Pittsburgh, Pennsylvania • Galveston, Texas + 1 more
- Conditions
- Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix
- Interventions
- Cervical cerclage
- Procedure
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years to 60 Years · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 3
- States / cities
- Washington D.C., District of Columbia • Philadelphia, Pennsylvania • Austin, Texas
- Conditions
- Cervical Insufficiency
- Interventions
- Sequential ultrasound, Transvaginal ultrasound
- Procedure
- Lead sponsor
- Intermountain Women and Children's Research
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 210 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Premature Birth
- Interventions
- Cervical cerclage, Vaginal Suppository Progesterone
- Procedure · Drug
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 329 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2029
- U.S. locations
- 2
- States / cities
- Charlotte, North Carolina • Philadelphia, Pennsylvania
- Conditions
- Short Cervical Length
- Interventions
- Vaginal progesterone, Placebo, Arabin Pessary
- Drug · Device
- Lead sponsor
- The George Washington University Biostatistics Center
- Other
- Eligibility
- Female only
- Enrollment
- 1,311 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2025
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • San Francisco, California • Denver, Colorado + 12 more